Handling data below the limit of quantification in mixed effect models
- PMID: 19452283
- PMCID: PMC2691472
- DOI: 10.1208/s12248-009-9112-5
Handling data below the limit of quantification in mixed effect models
Abstract
The purpose of this study is to investigate the impact of observations below the limit of quantification (BQL) occurring in three distinctly different ways and assess the best method for prevention of bias in parameter estimates and for illustrating model fit using visual predictive checks (VPCs). Three typical ways in which BQL can occur in a model was investigated with simulations from three different models and different levels of the limit of quantification (LOQ). Model A was used to represent a case with BQL observations in an absorption phase of a PK model whereas model B represented a case with BQL observations in the elimination phase. The third model, C, an indirect response model illustrated a case where the variable of interest in some cases decreases below the LOQ before returning towards baseline. Different approaches for handling of BQL data were compared with estimation of the full dataset for 100 simulated datasets following models A, B, and C. An improved standard for VPCs was suggested to better evaluate simulation properties both for data above and below LOQ. Omission of BQL data was associated with substantial bias in parameter estimates for all tested models even for seemingly small amounts of censored data. Best performance was seen when the likelihood of being below LOQ was incorporated into the model. In the tested examples this method generated overall unbiased parameter estimates. Results following substitution of BQL observations with LOQ/2 were in some cases shown to introduce bias and were always suboptimal to the best method. The new standard VPCs was found to identify model misfit more clearly than VPCs of data above LOQ only.
Figures






Similar articles
-
Likelihood based approaches to handling data below the quantification limit using NONMEM VI.J Pharmacokinet Pharmacodyn. 2008 Aug;35(4):401-21. doi: 10.1007/s10928-008-9094-4. Epub 2008 Aug 7. J Pharmacokinet Pharmacodyn. 2008. PMID: 18686017
-
Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models.J Pharmacokinet Pharmacodyn. 2011 Aug;38(4):423-32. doi: 10.1007/s10928-011-9201-9. Epub 2011 May 31. J Pharmacokinet Pharmacodyn. 2011. PMID: 21626437
-
Ways to fit a PK model with some data below the quantification limit.J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504. doi: 10.1023/a:1012299115260. J Pharmacokinet Pharmacodyn. 2001. PMID: 11768292
-
Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.Pharm Stat. 2010 Oct-Dec;9(4):313-30. doi: 10.1002/pst.400. Pharm Stat. 2010. PMID: 20043295
-
Conditioning on certain random events associated with statistical variability in PK/PD.J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):213-43. doi: 10.1007/s10928-005-0090-7. Epub 2005 Nov 7. J Pharmacokinet Pharmacodyn. 2005. PMID: 16283533 Review.
Cited by
-
Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics.CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):291-308. doi: 10.1002/psp4.12611. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33715307 Free PMC article.
-
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling.CPT Pharmacometrics Syst Pharmacol. 2024 Mar;13(3):374-385. doi: 10.1002/psp4.13089. Epub 2023 Dec 15. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38102814 Free PMC article.
-
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.Signal Transduct Target Ther. 2022 Apr 23;7(1):132. doi: 10.1038/s41392-022-00978-0. Signal Transduct Target Ther. 2022. PMID: 35461307 Free PMC article.
-
The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study.Pharmaceuticals (Basel). 2023 Aug 16;16(8):1166. doi: 10.3390/ph16081166. Pharmaceuticals (Basel). 2023. PMID: 37631081 Free PMC article.
-
Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: a Novel Method to Handle the Interval Censoring Caused by Measurement of Smaller Tumors.AAPS J. 2016 Mar;18(2):404-15. doi: 10.1208/s12248-015-9862-1. Epub 2016 Jan 12. AAPS J. 2016. PMID: 26757730 Free PMC article.
References
-
- FDA guidance for industry bioanalytical method validation. http://www.fdagov/cder/guidance/4252fnl.pdf (accessed 05/05/2007).
-
- Bergstrand M, Plan E, Kjellsson M, Karlsson MO. A comparison of methods for handling of data below the limit of quantification in NONMEM VI. PAGE 16 (2007) Abstr 1201 [www.page-meeting.org/?abstract=1201].
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources